Respiratory
1 drug is in development for Interstitial Lung Disease.
- Companies
- 1
- Clinical trials
- 20
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Interstitial Lung Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ap01 | Avalyn Pharma Inc. (AVLN) |
About this indication
Interstitial Lung Disease context
Respiratory·MeSH: Lung Diseases, Interstitial (D017563)
Also known as: Diffuse Parenchymal Lung Disease, Diffuse Parenchymal Lung Diseases, Interstitial Lung Diseases
Frequently asked questions
How many drugs are in development for Interstitial Lung Disease?
BioSniper tracks 1 drug in development for Interstitial Lung Disease across 1 company.
How many clinical trials target Interstitial Lung Disease?
There are 20 clinical trials targeting Interstitial Lung Disease tracked by BioSniper.